Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;14(5):434-443.
doi: 10.1007/s11897-017-0358-4.

Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction

Affiliations
Review

Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction

Jeremy Cypen et al. Curr Heart Fail Rep. 2017 Oct.

Abstract

Purpose of review: The use of biomarkers in heart failure (HF) is a rapidly changing field. The purpose of this review is to assess the current evidence of the use of biomarkers for risk stratification in patients with HF with preserved ejection fraction (HFpEF).

Recent findings: Despite differences in pathophysiology between HF with reduced ejection fraction and HFpEF, traditional HF biomarkers such as brain natriuretic peptide and troponin retain prognostic value in most HFpEF-specific populations. Biomarkers of key pathophysiologic components of HFpEF, such as myocardial fibrosis, remodeling, and systemic inflammation are also valuable prognostic markers. Further investigation into HF biomarkers may identify significant therapeutic targets for the treatment of HFpEF.

Keywords: Biomarkers; Heart failure; Prognosis; Risk stratification.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Med. 2011 Feb;43(1):60-8 - PubMed
    1. Circulation. 2016 Sep 27;134(13):e282-93 - PubMed
    1. Heart. 2010 Aug;96(16):1297-302 - PubMed
    1. J Am Coll Cardiol. 2007 Sep 11;50(11):1054-60 - PubMed
    1. Int J Cardiol. 2015;189:6-11 - PubMed

Publication types